Litcius/Paper detail

Overview of Changes to the Clinical and Laboratory Standards Institute <i>Performance Standards for Antimicrobial Susceptibility Testing,</i> M100, 31st Edition

Romney Humphries, April M. Bobenchik, Janet A. Hindler, Audrey N. Schuetz

2021Journal of Clinical Microbiology1,464 citationsDOIOpen Access PDF

Abstract

, Pseudomonas aeruginosa, and anaerobes), and lefamulin (Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae), and disk breakpoints are described for azithromycin and Neisseria gonorrhoeae. The rationale behind revised oxacillin MIC breakpoints for select staphylococci is discussed. Updates to test methods include a method for disk diffusion using positive blood culture broth and use of linezolid to predict tedizolid susceptibility. There is clarification on which drugs to suppress on bacteria isolated from the cerebrospinal fluid and clarification on the use of a caret symbol attached to the intermediate category ("I^") to indicate those antimicrobials that concentrate in the urine.

Topics & Concepts

AzithromycinAntimicrobialStreptococcus pneumoniaeMedicineMicrobiologyLinezolidClinical microbiologyStreptococcusMedical physicsErtapenemAntibacterial agentHaemophilus influenzaeBiologyAntibioticsAgar diffusion testBacterial Identification and Susceptibility TestingAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance
Overview of Changes to the Clinical and Laboratory Standards Institute <i>Performance Standards for Antimicrobial Susceptibility Testing,</i> M100, 31st Edition | Litcius